Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01897688 · ClinicalTrials.gov registry record · Phase 3
A Phase 3 Single Center Study of Islet Transplantation in Non-uremic Diabetic Patients
A Phase 3 study of Type 1 Diabetes and Severe Hypoglycemic Unawareness, sponsored by Northwestern University.
- Active
- Registry status
- Phase 3
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT01897688 is a Phase 3 study of Type 1 Diabetes and Severe Hypoglycemic Unawareness that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 40 participants, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01897688, a Phase 3 study of Type 1 Diabetes and Severe Hypoglycemic Unawareness, is active but no longer recruiting, sponsored by Northwestern University.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Type 1 diabetes is an autoimmune disease in which the insulin-producing pancreatic beta cells are destroyed, resulting in poor blood sugar control. The purpose of this study is to determine the safety and effectiveness of islet transplantation, combined with immunosuppressive medications, specifically using Campath as induction, for treating type 1 diabetes in individuals experiencing hypoglycemia unawareness and severe hypoglycemic episodes.
Conditions Studied
Interventions
- BIOLOGICAL Islet Cell Transplant
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2012-06 |
| Est. Completion | 2027-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01897688
The ClinicalTrials.gov registry entry for NCT01897688 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (95% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Type 1 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Islet Cell Transplant is the first listed.
NCT01897688 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT01897688 about?
NCT01897688 is a clinical study titled "A Phase 3 Single Center Study of Islet Transplantation in Non-uremic Diabetic Patients". Type 1 diabetes is an autoimmune disease in which the insulin-producing pancreatic beta cells are destroyed, resulting in poor blood sugar control. The purpose of this study is to determine the safety and effectiveness of islet transplantation, combined with immunosuppressive medications, specifical...
What is the current status of trial NCT01897688?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 40 participants. The study started on 2012-06. Estimated completion is 2027-03.
What conditions does trial NCT01897688 study?
This clinical trial studies the following conditions: Type 1 Diabetes, Severe Hypoglycemic Unawareness.
What interventions are being tested in trial NCT01897688?
The interventions under investigation include: Islet Cell Transplant (BIOLOGICAL).
Who is sponsoring clinical trial NCT01897688?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01897688 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant
RECRUITING · Phase 3
-
A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight
ACTIVE NOT RECRUITING · Phase 3
-
A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight
ACTIVE NOT RECRUITING · Phase 3
-
Liraglutide in Adolescents With Type 1 Diabetes
COMPLETED · Phase 3
-
Effects of Acipimox on Insulin Action, Vascular Function, and Muscle Function in Type 1 Diabetes
COMPLETED · Phase 3
-
A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy
COMPLETED · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.